Implant fixation enhanced by intermittent treatment with parathyroid hormone.
The intermittent administration of parathyroid hormone (PTH) increases the formation of bone by stimulating osteoblastic activity. Our study evaluates the possibility that intermittent treatment with PTH (1-34) may also enhance the implant-bone fixation of stainless-steel screws. Twenty-eight rats received one screw in either one (n = 8) or in both (n = 20) proximal tibiae. We administered either PTH (1-34) in a dosage of 60 microg/kg/day (n = 14) or vehicle (n = 14) over a period of four weeks. At the end of this time, the degree of fixation was assessed by measuring the removal torque on one screw in each rat (n = 28) and the pull-out strength on the contralateral screw (n = 20). PTH increased the mean removal torque from 1.1 to 3.5 Ncm (p = 0.001) and the mean pull-out strength from 66 to 145 N (p = 0.002). No significant differences in body-weight or ash weight of the femora were seen. Histological examination showed that both groups had areas of soft tissue at the implant-bone interface, but these appeared less in the PTH group. These results indicate that intermittent treatment with PTH may enhance the early fixation of orthopaedic implants.
Skripitz
R
R
Department of Orthopaedics, Lund University Hospital, Sweden.
Aspenberg
P
P
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001863:Bone Screws; D005593:Fracture Fixation, Internal / Q000379:methods*; D010281:Parathyroid Hormone / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley
D010281:Parathyroid Hormone